Table of Contents
What changed
Revenue was essentially flat at NZ$4,248m versus NZ$4,284m (–0.8%), but earnings inverted. PBT swung from a NZ$137m profit to a NZ$138m loss, a NZ$275m deterioration (–200.7%), and NPAT moved from +NZ$92m to –NZ$120m. The release attributes the swing primarily to an impairment and write-down on the Tradelink Australia business, layered onto a 20% volume decline in NZ residential. The interim dividend was not declared, versus 18.0 cents in HY23. Operating cash outflow narrowed to NZ$126m from NZ$203m, and capex fell to NZ$188m from NZ$247m, but gross borrowings rose NZ$476m to NZ$2,184m, cash fell to NZ$215m, and equity dropped NZ$223m to NZ$3,401m. Segment mix tilted further to New Zealand (65.3% of revenue, up 2.2pp), where EBIT margin compressed from roughly 10.1% to 6.8%.
What matters
- The Tradelink impairment is the swing factor, but NZ margin compression is the durable issue. The Australia write-down is disclosed as the primary driver of the NPAT swing, yet the NZ segment result fell from NZ$272m to NZ$188m on higher revenue share, which is a trading — not accounting — development.
- Leverage has weakened visibly. Net debt rose to approximately NZ$1,969m from NZ$1,436m (+NZ$533m in six months of comparison), and equity shrank 6.2%. With EBITDA not disclosed, an explicit net-debt/EBITDA ratio cannot be computed, but the direction is clearly adverse.
- Capital-return signal is material. A passed interim dividend (HY23 paid NZ$0.18) against a NZ$120m reported loss and a NZ$314m pre-lease free-cash-flow deficit implies the board is prioritising balance-sheet defence.
Expectations
No quantified guidance, order book, or forward-work figures were provided in the supplied excerpts, and there are no stated financial targets to measure against. Annualising HY24 revenue (NZ$8.5b) sits roughly in line with FY23 (NZ$8.47b), so the top line is broadly holding at the run-rate level. However, HY23 was first-half-light (39.1% of FY23 NPAT), meaning the seasonally stronger half historically does the heavy lifting — the release does not contain information to judge whether that shape can repeat given the 20% drop in NZ residential volumes and the Australia charge. On what is disclosed, the release supports a weaker-margin trajectory but does not support a quantified second-half view.
Quality of result
Low quality. The reported loss is flattered on one side by a NZ$21m tax benefit (effective tax rate 15.2% on a loss, versus 24.8% on profit in HY23) — PBT at –NZ$138m versus +NZ$137m is the cleaner operating read, widening the hit versus the prior period. The operating cash improvement (NZ$126m outflow vs NZ$203m) looks superficially positive, but pre-lease free cash flow was still about –NZ$314m because capex, though lower at NZ$188m, continued to exceed internal cash generation. Working capital was a drag: inventories rose to NZ$1,772m (+4.5%) and notional receivable days extended from 37.2 to 41.9, and inventory days from 72.0 to 75.9. Core trading earnings (ex-Tradelink charge, which is disclosed qualitatively rather than quantified) are implied to have fallen given the NZ segment result dropped NZ$84m independently of the Australia write-down.
Unresolved
- The quantum of the Tradelink impairment and write-down is not given in the supplied excerpts, so the split between non-recurring and underlying deterioration cannot be sized.
- EBITDA and a non-GAAP reconciliation bridge are not disclosed, preventing a net-debt/EBITDA leverage calculation and a clean view of significant items.
- There is no forward-work, order-book, or FY24 guidance figure, and no explicit capital-structure target (covenant headroom, debt maturity profile).
- It is unclear whether the dividend suspension is a one-period response to the loss or a reset of the payout framework.
- FX sensitivity is flagged as material (NZ$4m adverse FX on cash, meaningful Australian revenue) but not sized.
This briefing cannot assess whether the Tradelink charge is adequately sized, nor whether NZ residential volume weakness extends into the second half, because the supplied data contains neither the impairment quantum nor any forward trading commentary.
Key metrics
| Metric | HY24 | HY23 | Change |
|---|---|---|---|
| Revenue | $4248m | $4284m | -0.8% ↓ |
| Net profit after tax | −$120m | $92m | -230.4% ↓ |
| Net cash inflow from operating activities | −$126m | −$203m | +37.9% ↑ |
| Declared dividend per share | — | 18.0c | — |
| Operating profit | −$44m | $206m | -121.4% ↓ |
| Profit before tax | −$138m | $137m | -200.7% ↓ |
| Cash and cash equivalents | $215m | $272m | -21.0% ↓ |
| Total assets | $8925m | $8792m | +1.5% ↑ |
Reference: annolyse.ai/briefings/fbu-hy24
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| New Zealand | $2776m | $2705m | $188m | +2.2pp |
| Australia | $1414m | $1507m | $75m | -1.9pp |
| Other jurisdictions | $58m | $72m | $1m | -0.3pp |
Reference: annolyse.ai/briefings/fbu-hy24
Analytical metrics
| Metric | HY24 | HY23 | Context |
|---|---|---|---|
| Effective tax rate | n/m (loss period) | 24.8% | current loss period |
| FCF pre-lease | −$314.0m | −$450.0m | +$136.0m |
| FCF / NPAT | 261.7% | -489.1% | complementary conversion metric |
| Capex % revenue | 4.4% | 5.8% | — |
| Capex | $188.0m | $247.0m | −$59.0m |
| Debtor days | 41.9 | 37.2 | +4.7 days |
| Inventory days | 75.9 | 72.0 | +3.9 days |
| Net debt | $1969.0m | $1436.0m | +$533.0m |
| Gross borrowings | $2184.0m | $1708.0m | +$476.0m |
| Payout ratio vs NPAT | 0.0% | — | — |
| Payout ratio vs FCF pre-lease | 0.0% | — | covered |
| ROE (annualised) | -7.1% | 5.1% | Weakening |
| HY23 share of FY23 revenue | 50.6% | — | Other half was 49.4% |
| HY23 share of FY23 NPAT | 39.1% | — | Other half was 60.9% |
| Profit from continuing operations | −$120.0m | $103.0m | −$223.0m |
Reference: annolyse.ai/briefings/fbu-hy24
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.